A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, dose-escalation study of MM-111 with five different combination
treatments with the main goal of determining the safety of MM-111 with each combination.